Literature DB >> 15793201

SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes.

Per M Humpert1, Renate Neuwirth, Marco J Battista, Olga Voronko, Maximilian von Eynatten, Ilze Konrade, Gottfried Rudofsky, Thoralf Wendt, Andreas Hamann, Michael Morcos, Peter P Nawroth, Angelika Bierhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15793201     DOI： 10.2337/diacare.28.4.934

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  Bone marrow-derived cells and the vasculature in diabetes: from biomarker to treatment?

Authors:  N A Hanley
Journal:  Diabetologia       Date:  2007-07-26       Impact factor: 10.122

2.  Oxidative stress and glucose metabolism--is there a need to revisit effects of insulin treatment?

Authors:  P M Humpert
Journal:  Diabetologia       Date:  2010-01-06       Impact factor: 10.122

Review 3.  An underlying principle for the study of circulating progenitor cells in diabetes and its complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2008-07       Impact factor: 10.122

Review 4.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

Review 5.  Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.

Authors:  Gian Paolo Fadini; Douglas Losordo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2012-02-17       Impact factor: 17.367

6.  Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors:  G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

7.  Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes.

Authors:  C G Egan; R Lavery; F Caporali; C Fondelli; F Laghi-Pasini; F Dotta; V Sorrentino
Journal:  Diabetologia       Date:  2008-02-20       Impact factor: 10.122

8.  The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Authors:  Gian Paolo Fadini; Elisa Boscaro; Mattia Albiero; Lisa Menegazzo; Vera Frison; Saula de Kreutzenberg; Carlo Agostini; Antonio Tiengo; Angelo Avogaro
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

9.  Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation.

Authors:  M L Balestrieri; L Servillo; A Esposito; N D'Onofrio; A Giovane; R Casale; M Barbieri; P Paolisso; M R Rizzo; G Paolisso; R Marfella
Journal:  Diabetologia       Date:  2012-10-16       Impact factor: 10.122

Review 10.  Insulin signaling and life span.

Authors:  Angelo Avogaro; Saula Vigili de Kreutzenberg; Gian Paolo Fadini
Journal:  Pflugers Arch       Date:  2009-09-13       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.